Form 8-K - Current report:
SEC Accession No. 0000950170-22-004722
Filing Date
2022-03-28
Accepted
2022-03-28 08:00:38
Documents
27
Period of Report
2022-03-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axsm-20220325.htm   iXBRL 8-K 73288
2 EX-99.1 axsm-ex99_1.htm EX-99.1 56150
3 EX-99.2 axsm-ex99_2.htm EX-99.2 14609
4 GRAPHIC img36028404_0.jpg GRAPHIC 55016
5 GRAPHIC axsm-ex99_2s1.jpg GRAPHIC 42303
6 GRAPHIC axsm-ex99_2s2.jpg GRAPHIC 135159
7 GRAPHIC axsm-ex99_2s3.jpg GRAPHIC 51745
8 GRAPHIC axsm-ex99_2s4.jpg GRAPHIC 80720
9 GRAPHIC axsm-ex99_2s5.jpg GRAPHIC 42234
10 GRAPHIC axsm-ex99_2s6.jpg GRAPHIC 48764
11 GRAPHIC axsm-ex99_2s7.jpg GRAPHIC 53157
12 GRAPHIC axsm-ex99_2s8.jpg GRAPHIC 57614
13 GRAPHIC axsm-ex99_2s9.jpg GRAPHIC 66196
14 GRAPHIC axsm-ex99_2s10.jpg GRAPHIC 67650
15 GRAPHIC axsm-ex99_2s11.jpg GRAPHIC 62021
16 GRAPHIC axsm-ex99_2s12.jpg GRAPHIC 22050
  Complete submission text file 0000950170-22-004722.txt   1362274

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axsm-20220325_pre.xml EX-101.PRE 9441
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axsm-20220325_lab.xml EX-101.LAB 12798
19 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axsm-20220325.xsd EX-101.SCH 2469
21 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20220325_htm.xml XML 4540
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 22773222
SIC: 2834 Pharmaceutical Preparations